Related Experiment Video
Updated: Jan 26, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
Jin Chen1, Hui Liu1, Lijuan Li1
1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Background:
Renal impairment (RI) is a most common complication of multiple myeloma (MM), which is associated with an increased risk of early death and worse survival.
Methods:
We retrospectively analyzed clinical features and outcomes of 77 MM patients over 70 years old and compared the differences between with and without RI groups.
Results:
The percentage of elder MM patients with RI was 61%. Hemoglobin level was a protective factor (OR = 0.954, P = 0.033), while creatinine and hypertension were hazards (OR = 1.288, P < 0.001 and OR = 30.12, P = 0.008). And the percentages of patients with mild-to-moderate RI and moderate-to-severe RI were 40.4% and 59.6%. Complete remission (CR) rate was higher in patients treated with bortezomib (33.3%) than those with non-bortezomib treatment (3.33%) (P = 0.007). Meanwhile, CRrenal was higher in patients with bortezomib (58.3%) than non-bortezomib treatment (22.2%) (P = 0.025). The median OS of the patients with RI treated with bortezomib was longer than those with non-bortezomib regimens (15.0 vs 6.0 months, P = 0.001). The same result was observed in the patients with moderate-to-severe RI (13.0 vs 6.0 months, P = 0.007). The median OS of the patients with RI receiving the bortezomib regimens (15 months) was longer than those with non-bortezomib regimens (6.0 months) (P = 0.001).
Conclusion:
Hemoglobin is a protective factor in elder patients with RI, while creatinine and hypertension were hazards. The median OS of elderly patients with RI was worse, and bortezomib can improve the CR rate in these patients.
Insights
Elderly multiple myeloma patients with renal impairment face worse outcomes. Bortezomib treatment improved remission rates and overall survival in this high-risk group.
Area of Science:
- Hematology
- Nephrology
- Geriatrics
Background:
- Renal impairment (RI) is a frequent complication in multiple myeloma (MM).
- RI in MM patients is linked to increased mortality and poorer survival rates.
Purpose of the Study:
- To analyze clinical features and outcomes of elderly MM patients with renal impairment.
- To compare outcomes between MM patients with and without RI, focusing on treatment effects.
Main Methods:
- Retrospective analysis of 77 MM patients aged over 70.
- Comparison of clinical characteristics and survival between patients with and without RI.
- Evaluation of treatment efficacy, particularly bortezomib, on remission and survival.
Main Results:
- 61% of elderly MM patients had renal impairment.
- Low hemoglobin, high creatinine, and hypertension were associated with worse outcomes in RI patients.
- Bortezomib treatment significantly improved complete remission (CR) and overall survival (OS) in elderly MM patients with RI.
Conclusions:
- Hemoglobin level is a protective factor, while creatinine and hypertension are risk factors in elderly MM patients with RI.
- Elderly MM patients with RI have worse median overall survival.
- Bortezomib therapy enhances CR rates and survival for elderly MM patients with renal impairment.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

